Clausenlanins A and B, Two Leucine-Rich Cyclic Nonapeptides from Clausena lansium.
Hu, Shai-Ping; Song, Wei-Wu; Zhao, Si-Meng; Tan, Ning-Hua
2017
Source PublicationNatural products and bioprospecting
ISSN2192-2195
Volume7Issue:4Pages:307-313
AbstractTwo new cyclic nonapeptides, named clausenlanins A (1) and B (2), were isolated from the roots and rhizomes of Clausena lansium. Their structures were elucidated as cyclo-(Gly1-L-Leu2-L-Ile3-L-Leu4-L-Leu5-L-Leu6-L-Leu7-L-Leu8-L-Leu9) (1) and cyclo-(Gly1-L-Leu2-L-Val3-L-Leu4-L-Leu5-L-Leu6-L-Leu7-L-Leu8-L-Leu9) (2) respectively on the basis of extensive spectroscopic analysis, particularly 2D NMR spectra taken at the temperature of 338 or 303K and MS.
Document Type期刊论文
Identifierhttp://ir.kib.ac.cn/handle/151853/64833
Collection植物化学与西部植物资源持续利用国家重点实验室
Recommended Citation
GB/T 7714
Hu, Shai-Ping,Song, Wei-Wu,Zhao, Si-Meng,et al. Clausenlanins A and B, Two Leucine-Rich Cyclic Nonapeptides from Clausena lansium.[J]. Natural products and bioprospecting,2017,7(4):307-313.
APA Hu, Shai-Ping,Song, Wei-Wu,Zhao, Si-Meng,&Tan, Ning-Hua.(2017).Clausenlanins A and B, Two Leucine-Rich Cyclic Nonapeptides from Clausena lansium..Natural products and bioprospecting,7(4),307-313.
MLA Hu, Shai-Ping,et al."Clausenlanins A and B, Two Leucine-Rich Cyclic Nonapeptides from Clausena lansium.".Natural products and bioprospecting 7.4(2017):307-313.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Hu, Shai-Ping]'s Articles
[Song, Wei-Wu]'s Articles
[Zhao, Si-Meng]'s Articles
Baidu academic
Similar articles in Baidu academic
[Hu, Shai-Ping]'s Articles
[Song, Wei-Wu]'s Articles
[Zhao, Si-Meng]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Hu, Shai-Ping]'s Articles
[Song, Wei-Wu]'s Articles
[Zhao, Si-Meng]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.